Skip to main content
. 2009 Jun 6;3:59. doi: 10.1186/1752-0509-3-59

Table 3.

Over-represented known CREs in N-bicluster 9.

Cis Regulatory Element % Present in Whole Genome % Present in N-bicluster 9 P-value
BoxII 49.32% 66.67% 6.90E-05
RAV1A 84.00% 94.44% 1.94E-04
Wbox 80.83% 92.06% 3.40E-04
MYB2CONSENSUSAT 63.96% 78.57% 3.43E-04
RY_repeat 5.36% 13.49% 4.09E-04
ebox 86.24% 95.24% 5.87E-04
DPBF1&2_binding_site_motif 64.32% 77.78% 9.66E-04
ARF 45.03% 59.52% 0.001096
AtMYC2_BS_in_RD22 44.10% 57.94% 0.001509
MYB4 72.72% 84.13% 0.001727
Bellringer/replumless/pennywise BS1 IN AG 42.04% 55.56% 0.001932
SV40 25.69% 38.10% 0.001954
ATB2/AtbZIP53/AtbZIP44/GBF5BS in ProDH 48.52% 61.90% 0.002188
CCA1 34.48% 47.62% 0.002400
ABRE like 26.46% 38.10% 0.004204
AtMYB2 BS in RD22 16.57% 26.19% 0.005280
T box 58.94% 70.63% 0.006024
LFY 62.88% 73.81% 0.007078

Results of a promoter sequence analysis of genes from N-bicluster 9 with the Fisher Exact Test used to determine CRE frequency over-representation in N-bicluster 9. Over-representation of CREs was determined by comparing the frequency of these sites in N-bicluster 9 genes to the frequency in the whole genome as a background. Significance was determined using a 5% FDR cut-off. Indicated in this table is the percentage of genes from the whole genome and N-bicluster 9 that contain these elements and the respective p-values for over-representation. *P-values 0.01–0.05; **P-values 0.001–0.01; ***P-values < 0.001.